ClinVar Miner

Submissions for variant NM_000051.4(ATM):c.2804C>T (p.Thr935Met)

gnomAD frequency: 0.00006  dbSNP: rs3218708
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 14
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000131651 SCV000186678 likely benign Hereditary cancer-predisposing syndrome 2019-03-15 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
GeneDx RCV000211988 SCV000209713 uncertain significance not provided 2024-01-23 criteria provided, single submitter clinical testing Observed in individuals with breast cancer, colon cancer, other cancers, and/or colon polyps, but also in unaffected controls (PMID: 16832357, 19781682, 26689913, 25980754, 28779002, 27978560, 28135145, 29596542, 31882575, 36243179); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25801821, 26689913, 28135145, 19781682, 27978560, 28779002, 22529920, 25980754, 16832357, 29596542, 31882575, 33471991, 29641532, 36243179, 35982160)
Labcorp Genetics (formerly Invitae), Labcorp RCV000204695 SCV000260536 likely benign Ataxia-telangiectasia syndrome 2024-01-24 criteria provided, single submitter clinical testing
Counsyl RCV000204695 SCV000800392 uncertain significance Ataxia-telangiectasia syndrome 2018-06-04 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000131651 SCV000910760 likely benign Hereditary cancer-predisposing syndrome 2016-05-24 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000780917 SCV000918568 uncertain significance not specified 2018-10-19 criteria provided, single submitter clinical testing Variant summary: ATM c.2804C>T (p.Thr935Met) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 282986 control chromosomes, predominantly at a frequency of 0.0001 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than expected for a pathogenic variant in ATM causing Breast Cancer (6.4e-05 vs 0.001), allowing no conclusion about variant significance. The variant, c.2804C>T, has been reported in the literature in individuals affected with colorectal cancer (Yurgelun_2015, Yurgelun_JAMAOnc_2016) but also in controls (Tavtigian_2009, Renwick_2006). These reports do not provide unequivocal conclusions about association of the variant with breast cancer. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (VUS x3, likely benign x1). Based on the evidence outlined above, the variant was classified as uncertain significance.
Mendelics RCV000204695 SCV001138477 uncertain significance Ataxia-telangiectasia syndrome 2019-05-28 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000131651 SCV002532841 uncertain significance Hereditary cancer-predisposing syndrome 2021-09-07 criteria provided, single submitter curation
St. Jude Molecular Pathology, St. Jude Children's Research Hospital RCV002291569 SCV002584618 uncertain significance Familial cancer of breast 2022-09-08 criteria provided, single submitter clinical testing The ATM c.2804C>T (p.Thr935Met) missense change has a maximum subpopulation frequency of 0.012% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). The in silico tool REVEL predicts a benign effect on protein function, but to our knowledge this prediction has not been confirmed by functional studies. This variant has been reported in individuals with breast or colorectal cancer (PMID: 25980754, 27978560, 28135145, 28779002, 31882575, 33471991). This variant has been reported in 2 individuals in a database of women older than 70 years of age who have never had cancer (FLOSSIES database, https://whi.color.com/). To our knowledge, this variant has not been reported in individuals with ataxia telangiectasia. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance.
Myriad Genetics, Inc. RCV002291569 SCV005083925 likely benign Familial cancer of breast 2024-05-10 criteria provided, single submitter clinical testing This variant is considered likely benign. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752].
Mayo Clinic Laboratories, Mayo Clinic RCV000211988 SCV005412457 uncertain significance not provided 2024-03-06 criteria provided, single submitter clinical testing BP4, PM2
Institute for Biomarker Research, Medical Diagnostic Laboratories, L.L.C. RCV000131651 SCV005415616 uncertain significance Hereditary cancer-predisposing syndrome 2024-11-12 criteria provided, single submitter clinical testing The missense variant NM_000051.4(ATM):c.2804C>T (p.Thr935Met) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. There is a moderate physicochemical difference between threonine and methionine. The gene ATM has a low rate of benign missense variation as indicated by a high missense variants Z-Score of 2.52. The p.Thr935Met variant is not predicted to introduce a novel splice site by any splice site algorithm. The p.Thr935Met missense variant is predicted to be tolerated by both SIFT or PolyPhen2. The methionine residue at codon 935 of ATM is present in Squirrel monkey and 23 other mammalian species. The nucleotide c.2804 in ATM is not conserved according to a GERP++ and PhyloP analysis of 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance
Department of Pathology and Laboratory Medicine, Sinai Health System RCV001358229 SCV001553903 uncertain significance Familial pancreatic carcinoma no assertion criteria provided clinical testing The ATM p.Thr935Met variant was identified in 4 of 32596 proband chromosomes (frequency: 0.0001) from individuals or families with breast cancer, colorectal cancer or Lynch syndrome and was present in 1 of 11718 control chromosomes (frequency: 0.0001) from healthy individuals (Decker 2017, Pearlman 2017, Renwick 2006, Yurgelun 2015, Yurgelun 2017). The variant was also identified in dbSNP (ID: rs3218708) as "With Uncertain significance allele", ClinVar (classified as likely benign by Ambry Genetics and Color; and as uncertain significance by Invitae, Counsyl, GeneDx and one other submitter). The variant was not identified in LOVD 3.0. The variant was identified in control databases in 15 of 277146 chromosomes at a frequency of 0.00005 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 1 of 24034 chromosomes (freq: 0.00004), European in 13 of 126690 chromosomes (freq: 0.0001), and South Asian in 1 of 30782 chromosomes (freq: 0.00003), while the variant was not observed in the Other, Latino, Ashkenazi Jewish, East Asian, or Finnish populations. The p.Thr935 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.
PreventionGenetics, part of Exact Sciences RCV004739457 SCV005348580 likely benign ATM-related disorder 2024-09-13 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.